Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Small business owners can enhance their wealth with smart strategies. Learn how to grow your assets effectively.
21,863 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
New wage data in early 2026 shows the payoff from switching jobs is fading. Movers earned roughly 4% in January, whil...
SentinelOne's Tomer Weingarten argues that Microsoft shows greater vulnerability exposure than any peer, boosting the...
AI-driven demand and easing supply bottlenecks push chipmakers into the spotlight. Here’s a timely look at the best s...
A senior Iranian official publicly mocks Trump's appeal to help reopen the Hormuz Strait as tensions intensify, with ...
Five high-yield dividend stocks trading under $20 are drawing renewed interest as rate volatility persists, offering ...
Solana’s stablecoin liquidity reached a new peak in February 2026, while open interest rose to near $6 billion, signa...
New York's transit agency filed a federal lawsuit against the federal government after nearly $60 million in subway f...
New heart health guidelines urge Lp(a) testing for at-risk adults, sending demand for diagnostics higher. This report...
Global equities outside the US have surged as growth improves and the dollar weakens. This article highlights three E...
A jury finds elon musk liable for misleading investors during Twitter's $44 billion takeover, signaling a landmark ru...
Three cruise stocks rise and fall on 2025 results and 2026 guidance. This report weighs Royal Caribbean, Carnival, an...